Biotech NewsAclaris (ACRS) Advances Groundbreaking Therapies for Autoimmune Diseases BioTech Health XNovember 20, 2024 Aclaris Therapeutics Inc. (ACRS) is a biopharmaceutical company specializing in developing innovative therapies for immuno-inflammatory diseases. With a… 0 Shares 0 0 0 0 0 0 0
Biotech NewsPulmonx (LUNG) Reports $68.7M Revenue with 28% Growth and COPD Innovations BioTech Health XNovember 17, 2024 Pulmonx Corporation (LUNG), a leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), reported a record… 0 Shares 0 0 0 0 0 0 0
Biotech NewsUroGen (URGN) Posts $25.2M Q3 Revenue, Targets $5B Market with UGN-102 Launch BioTech Health XNovember 17, 2024 UroGen Pharma Ltd. (URGN), a biotechnology company revolutionizing cancer care, announced Q3 2024 revenue of $25.2 million, a… 0 Shares 0 0 0 0 0 0 0
Biotech NewsABBV-RGX-314 Gene Therapy Reduces nAMD Injections in Bilateral Study BioTech Health XNovember 14, 2024 In a major advancement for treating neovascular age-related macular degeneration (nAMD), the investigational gene therapy ABBV-RGX-314 of Regenxbio… 0 Shares 0 0 0 0 0 0 0
Biotech NewsRigel (RIGL)’s Q3 2024 Revenue Hits $55.3M BioTech Health XNovember 12, 2024 Rigel Pharmaceuticals, Inc. (RIGL), a biotech leader in hematologic disorders and oncology, reported strong Q3 2024 financial growth… 0 Shares 0 0 0 0 0 0 0
Biotech NewsLakeside Holding (LSH) Acquires Hupan Pharmaceutical to Enter China’s Medical Logistics Market BioTech Health XNovember 11, 2024 Lakeside Holding Limited (LSH), a U.S.-based leader in cross-border supply chain solutions, has officially expanded into the medical… 0 Shares 0 0 0 0 0 0 0
Biotech NewsAutolus (AUTL) Reports Obe-cel Launch Progress and Strong Cash Position in Q2 2024 BioTech Health XNovember 10, 2024 Autolus Therapeutics plc (AUTL), a leader in T-cell therapies, announced its Q2 2024 financial results and business updates.… 0 Shares 0 0 0 0 0 0 0
Biotech NewsFDA Clears CEL-SCI’s Multikine Study for Head and Neck Cancer BioTech Health XNovember 8, 2024 CEL-SCI Corporation (CVM), a leader in immunotherapy, announced FDA approval of its patient selection strategy for the upcoming… 0 Shares 0 0 0 0 0 0 0
Biotech NewsAethlon (AEMD) Reports Q1 2024 Results and Advances Cancer and Virus Treatment Trials BioTech Health XNovember 7, 2024 Aethlon Medical, Inc. (AEMD), a pioneering company in cancer and infectious disease therapies, has reported its fiscal Q1… 0 Shares 0 0 0 0 0 0 0
Biotech NewsTreace Medical (TMCI) Reports 11% Revenue Growth in Q3 2024 BioTech Health XNovember 6, 2024 Treace Medical Concepts, Inc. (TMCI), a leading innovator in the medical technology space focused on bunion treatment, announced… 0 Shares 0 0 0 0 0 0 0
Biotech NewsTaysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials BioTech Health XNovember 5, 2024 Taysha Gene Therapies, Inc. (TSHA), a leader in developing AAV-based gene therapies for severe central nervous system diseases,… 0 Shares 0 0 0 0 0 0 0